Amgen (Sr)Product Manager in Shanghai, China
The (Sr)Product Manager is responsible for Repatha marketing program design and execution. This role will be led by the Assoc. Marketing Dir of CVBU to analyze opportunities and develop plans to optimize Repatha business.
Responsible for Repatha marketing programs and operational matters.
Seamless execution of strategy and development/tracking of key performance indicators (KPIs) to measure brand success at the strategic and tactical level.
Accountability toward the development and tracking of the Repatha non-hospital business.
Develop and champion Long Product Strategy for Repatha.
Strategic/financial/tactical KPI development/tracking.
Analysis of customer brand/competitor performance, as well as contract performance.
Lead Long Range Plan, LE/forecast, quarterly business review processes.
Coordinate with Medical, Commercial Excellence, Strategic Planning, Finance and other cross-functional partners.
Budget owner/tracking/cross functional allocation
Comply with all relevant company compliance, policies, procedures and work practices.
Support other activities as required by the line manager.
At least two years’ experience in MKT
Retail or consumer health is preferred.
Good skill in English(oral; written)
Good skill in data analysis (excel; PPT)
If you're seeking a career where you can truly make a difference in the lives of others, a career where you can work at the absolute forefront of biotechnology with the top minds in the field, you'll find it at Amgen.
Amgen, a biotechnology pioneer, discovers, develops and delivers innovative human therapeutics. Our medicines have helped millions of patients in the fight against cancer, kidney diseases, rheumatoid arthritis and other serious illnesses.
As an organization dedicated to improving the quality of life for people around the world, Amgen fosters an inclusive environment of diverse, ethical, committed and highly accomplished people who respect each other but compete intensely to win. Together, we live the Amgen values as we continue advancing science to serve patients.